Komori
Statutory disclosure document4888STELLA PHARMA CORPORATIONPharmaceuticals

Report on the Transfer of Shares Issued through a Third-Party Allotment (New Shares)

The third-party allottee, CVI Investments, Inc., transferred the 300,000 allotted common shares to BofA Securities Co., Ltd. off-market. The cumulative number of shares transferred reached 600,000.

Worth reading
57In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Neutral
Direction inferred from the company’s description.
Scale
300000
shares
Wording
Definitive
How definitive the wording is.

Decision and Details

Transfer of shares allotted through a third-party allotment

Implementation17 November 2026 (actual)
AmountTransfer price: ¥129,600,000 in total (¥432 per share)
Quantity / scaleNumber of shares transferred: 300,000; number of shares allotted: 1,000,000 common shares; cumulative number of shares transferred: 600,000
Reason

For the purpose of moving the shares to a swap position

Decision and Details
ItemDetails
Matter CoveredTransfer of shares allotted through a third-party allotment
Implementation Date17 November 2026 (actual)
AmountTransfer price: ¥129,600,000 in total (¥432 per share)
Quantity / scaleNumber of shares transferred: 300,000; number of shares allotted: 1,000,000 common shares; cumulative number of shares transferred: 600,000
ReasonFor the purpose of moving the shares to a swap position
Related previous disclosuresThe Company's shares allotted through a third-party allotment on 4 November 2026 (no title stated)
Items this document does not state (6)
Decision-Making BodyDecision DatePeriod CoveredImpact on Business PerformanceGoverning RuleFuture plans

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

For the purpose of moving the shares to a swap position.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.